Related Experiment Video

Updated: Aug 16, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Toll-like receptors, inflammation and cancer

Min-Fu Tsan1

  • 1Research Service, Veterans Affairs Medical Center, 50 Irving Street, NW, Washington, DC 20422, USA. min-fu.tsan2@med.va.gov

Seminars in Cancer Biology
|September 13, 2005
PubMed

Insights

Toll-like receptors (TLRs) are vital for immunity, but cancer can suppress immune cells. Research explores if endogenous TLR ligands contribute to this immunosuppression, potentially impacting cancer immunotherapy success.

Area of Science:

  • Immunology
  • Oncology
  • Microbiology

Background:

  • Toll-like receptors (TLRs) are key in host defense against pathogens via pathogen-associated molecular patterns (PAMPs).
  • Microbial components acting via TLRs are used as adjuvants in cancer immunotherapy.
  • Cancer progression often leads to immunosuppression, limiting immunotherapy efficacy.

Purpose of the Study:

  • To investigate the potential role of endogenous molecules as Toll-like receptor (TLR) ligands in cancer-induced immunosuppression.
  • To explore whether endogenous TLR ligands contribute to chronic inflammation and immune cell dysfunction during cancer progression.

Main Methods:

  • Review of existing literature on TLR signaling in cancer and immunity.
  • Analysis of proposed mechanisms linking endogenous TLR ligands to immune suppression.
  • Identification of knowledge gaps and areas for future research.

Main Results:

  • Endogenous molecules are suggested as potential TLR ligands, possibly released during cancer progression.
  • These endogenous ligands may promote chronic inflammation, recruit myeloid suppressor cells, and impair T-cell and NK cell function.
  • A significant concern is the potential contamination of reported endogenous ligands with PAMPs, complicating interpretation.

Conclusions:

  • The existence and precise role of endogenous TLR ligands in cancer-associated immunosuppression require further rigorous investigation.
  • Clarifying the contribution of endogenous TLR ligands is crucial for understanding and improving cancer immunotherapy strategies.

More Related Videos

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces07:55

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

Published on: January 7, 2020

Related Concept Videos

Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...